Navigation Links
ImpactRx Announces Expansion and Addition of Physician Information Networks
Date:11/2/2007

Data Expanded for Oncology, Neurology and Urology; Initiated for

Dermatology and OB/GYN

MOUNT LAUREL, N.J., Nov. 2 /PRNewswire/ -- ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on physicians' prescribing behavior, announced today that it is expanding its nationwide physician information networks in alignment with emerging market trends and rising client demand. ImpactRx is increasing the size of its longitudinal, smartphone-enabled physician research panels in three key specialties, and is initiating data collection in two additional specialties to broaden the scope of its data and services.

ImpactRx recently increased the size of its neurology specialty panel by 50 percent, is completing a similar-sized increase to its panel of urologists, and plans to expand its groundbreaking oncology research panel beginning in the first quarter of 2008.

"The oncology market has become increasingly competitive as the availability of new treatment alternatives grows and companies promote more aggressively for a share of the oncologist's attention," said Jill Walton, recently appointed Managing Director and Vice President of ImpactRx's Oncology Business Unit. "Clients need to accurately assess performance, and ImpactRx's point-of-promotion and point-of-treatment model provides unmatched insight into sales execution and effectiveness. This expansion enhances our ability to provide our clients with the information edge needed to compete and win in the oncology marketplace," said Walton.

In addition to expanding its existing physician panels, ImpactRx is adding new panels for two important specialties, dermatologists and obstetricians/gynecologists.

"This extension of our information networks puts us in a stronger position to support trends emerging across our customer base," said John Kain, ImpactRx's Vice President of Marketing. "We will be much better situated to support
'/>"/>

SOURCE ImpactRx, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 3Van Andel Institute Cuts Ribbon on $178 Million Expansion 4Nplate(R) Data From MDS Studies Presented at ASH 2Nplate(R) Data From MDS Studies Presented at ASH 3Nplate(R) Data From MDS Studies Presented at ASH 4Nplate(R) Data From MDS Studies Presented at ASH 5Nplate(R) Data From MDS Studies Presented at ASH 6Nplate(R) Data From MDS Studies Presented at ASH 7Nplate(R) Data From MDS Studies Presented at ASH 8Nplate(R) Data From MDS Studies Presented at ASH 9Nplate(R) Data From MDS Studies Presented at ASH 10Star Scientific Breaks New Ground Plans FDA Filing for Approval of First Modified Risk Tobacco Product 3B Nominates Curtis Wright MD MPH for FDA Ad 57981 1Star Scientific Breaks New Ground Plans FDA Filing for Approval of First Modified Risk Tobacco Product 3B Nominates Curtis Wright MD MPH for FDA Ad 57981 2Star Scientific Breaks New Ground Plans FDA Filing for Approval of First Modified Risk Tobacco Product 3B Nominates Curtis Wright MD MPH for FDA Ad 57981 3Star Scientific Breaks New Ground Plans FDA Filing for Approval of First Modified Risk Tobacco Product 3B Nominates Curtis Wright MD MPH for FDA Ad 57981 4Star Scientific Breaks New Ground Plans FDA Filing for Approval of First Modified Risk Tobacco Product 3B Nominates Curtis Wright MD MPH for FDA Ad 57981 5Bon Secours Richmond Named A Top Ten 2009 Working Mother 100 Best Company 57977 1Bon Secours Richmond Named A Top Ten 2009 Working Mother 100 Best Company 57977 2Bon Secours Richmond Named A Top Ten 2009 Working Mother 100 Best Company 57977 3Bon Secours Richmond Named A Top Ten 2009 Working Mother 100 Best Company 57977 4Healthcare Reform 3A Driving Healthcare Costs Down Through Improved Efficiency and Quality of Care 57974 1Healthcare Reform 3A Driving Healthcare Costs Down Through Improved Efficiency and Quality of Care 57974 2Healthcare Reform 3A Driving Healthcare Costs Down Through Improved Efficiency and Quality of Care 57974 3